承業醫 News Releases

Chengye Medical Announces Results of Second Treasury Stock Buyback

Chengye Medical has announced the execution results of its second treasury stock buyback, successful… · 2026-07-04

Hsin-An Health Business Co., Ltd. Announces Shareholder Meeting Resolution on Dividend Distribution

Hsin-An Health Business Co., Ltd. has resolved to distribute stock dividends totaling NT$1,572,110 f… · 2026-06-30

Chengye Medical's Key Subsidiary Fukan Vitality Pharmaceutical Announces Board Resolution on Cash Capital Increase and New Share Issuance

Fukan Vitality Pharmaceutical Co., Ltd., a key subsidiary of Chengye Medical, has announced a board … · 2026-06-26

Chengye Medical Announces Shareholder Dividend Distribution Resolved by Its Key Subsidiary Fu Kang Active Pharmaceutical Co., Ltd.

Fu Kang Active Pharmaceutical Co., Ltd., a key subsidiary of Chengye Medical, has announced the dist… · 2026-06-26

【Chengyee Medical】Information Regarding Corporate Information Session on 2026/04/16

Chengyee Medical will hold a corporate information session on April 16, 2026, to discuss its busines… · 2026-04-16

Chien Yeh BioMedical: Clarification of Media Report

Chien Yeh BioMedical (4164) issued a material information announcement on April 17, 2026, clarifying… · 2026-04-17

[Cheng Yeh Medical] February 2026 Revenue Reaches NT$269 Million (YOY +22.8%)

Cheng Yeh Medical (4164), a leading provider of radiotherapy oncology equipment and services, announ… · 2026-02-01

[Chunghwa Medical] Announces Approval of Full Board Re-election at 115 Annual General Meeting

Chunghwa Medical (4164) held its annual general meeting on June 4, 115, and approved the full re-ele… · 2026-06-04

[ACME] Announcement on Adjustment of Cash Dividend Payout Ratio

ACME (6625) announced an adjustment to its cash dividend payout ratio, changing the cash dividend pe… · 2026-06-10

[CHENG Uei Medical] Announcement regarding the reduction of held subsidiaries

CHENG Uei Medical announced a reduction in the number of its subsidiaries due to group operational p… · 2026-06-05

Shengye Medical Reports May 2026 Revenue of JPY 544 Million (Up +80.2% Year-on-Year)

Shengye Medical announced its revenue for May 2026 reached JPY 544 million, representing an 80.2% in… · 2026-05-01

[CHENG UEI] Announcement of the Board of Directors' Resolution on Dividend Distribution for Subsidiary Hualin Co., Ltd.

Cheng Uei announced that the Board of Directors of its subsidiary, Hualin Co., Ltd., has resolved to… · 2026-05-25

[CHENG UEI] Announcement Regarding the Board's Election of Chairman and Vice-Chairman

CHENG UEI held a board meeting on June 4, 115, and following the comprehensive board election at the… · 2026-06-04

[CHBE] Shareholders' meeting approves lifting of non-compete for new directors

CHBE held its shareholders' meeting on June 4, 2026, approving the lifting of non-compete restrictio… · 2026-06-04

Chengye Medical announces Audit Committee changes

Chengye Medical appointed committee on 2023-06-04, replacing Liao Gengwang with Lin Yifu. · 2026-06-04

Chengye Medical Announces 2026 Shareholder Resolutions

Profit distribution, bylaws amendment, FY114 reports, board election approved. · 2026-06-04

Cheng-Yi Medical Sustainability Committee Term Expiry

Committee terms expired; old members left, new members still pending appointment. · 2026-06-04

[Chengye Medical] 6th Compensation Committee term ends

Three directors of Chengye Medical 6th Compensation Committee ended terms; new members pending · 2026-06-04

[CHENG UEI] Announcement of Dividend Distribution Resolution by Key Subsidiary Xingye Biotech

On May 25, 2026, Xingye Biotech, a key subsidiary of CHENG UEI, held a board meeting and decided to … · 2026-05-25

[CHENG UEI] Announcement of Dividend Distribution Resolution by Subsidiary Jiuhe Technology

On May 25, 2026, Jiuhe Technology, a subsidiary of CHENG UEI, held a board meeting and decided to di… · 2026-05-25

[CHENG UEI] Announcement regarding the Board of Directors' resolution on dividend distribution for subsidiary Dong Lin Instrument Co., Ltd.

CHENG UEI (4164) announced that the Board of Directors of its subsidiary, Dong Lin Instrument, has r… · 2026-05-25

CHENG-HE Medical March 2026 Revenue NT$577 million (YoY +3.4%)

CHENG-HE Medical's monthly revenue for March 2026 was NT$577 million, an increase of 3.4% year-over-… · 2026-03-01

[CHC] Board of Directors' Resolution on the Convening of the Year 115 Annual Shareholders' Meeting (Additional Proposal)

CHC Healthcare Group announced its Annual Shareholders' Meeting scheduled for June 4, Year 115. A ke… · 2026-04-22

[CHENG UEI] Announcement of Ex-Dividend Date

CHENG UEI has announced its ex-dividend date. The company will distribute 1.1 TWD in cash dividends … · 2026-05-29

[Ching-Yeh Medical] Announcement regarding the Board of Directors' resolution on dividend distribution for subsidiary, Yi-Shi-Ji Health Management Consulting Co., Ltd.

Yi-Shi-Ji Health Management Consulting, a subsidiary of Ching-Yeh Medical, announced a cash dividend… · 2026-05-25

[CHENG UEI] Announcement regarding the Board of Directors' resolution on non-distribution of dividends for subsidiary Shin Ho Biotechnology Co., Ltd.

Shin Ho Biotechnology, a subsidiary of CHENG UEI, announced that its Board of Directors resolved not… · 2026-05-25

[CHENG UEI] Announcement of Dividend Distribution Resolution by Key Subsidiary Jiuhe Medical Instruments

On May 25, 2026, Jiuhe Medical Instruments, a key subsidiary of CHENG UEI, held a board meeting and … · 2026-05-25

[Ching-Yeh Medical] Announcement of Board Resolution on Dividend Distribution by Subsidiary, Jiu-He Biotech

Ching-Yeh Medical's subsidiary, Jiu-He Biotech, has resolved to distribute cash dividends totaling 4… · 2026-05-25

[CHENG UEI] Announcement of Dividend Distribution Resolution by Subsidiary Duomoshi

On May 25, 2026, Duomoshi, a subsidiary of CHENG UEI, held a board meeting and decided to distribute… · 2026-05-25

Syentec: April 2026 Monthly Revenue NT$304 Million (YoY +21.8%)

Syentec announced its April 2026 monthly revenue reached NT$304 million, marking a significant 21.8%… · 2026-04-01

【Cheng Yeh Medical】Company announces that its important subsidiary, Xing Ye Biotechnology Co., Ltd., has signed a syndicated loan agreement with a banking consortium

Cheng Yeh Medical's important subsidiary, Xing Ye Biotechnology Co., Ltd., has signed a syndicated l… · 2026-05-08

Chengyey Company's Outstanding Guarantee Balance Reaches the Announcement Standard of Article 25, Paragraph 1, Item 4 of the "Regulations Governing Lending and Guaranteeing of Funds by Public Companies"

On May 6, 2026, Chengyey Company approved a new guarantee of TWD 5.3 billion (approx. USD 5.3 millio… · 2026-05-06

United Bio-Medtech Announces Board Resolution for Second Treasury Stock Buyback

United Bio-Medtech's board of directors resolved on May 6, 2026, to implement a second treasury stoc… · 2026-05-06

【Synergy Medical】Announcement of Board Approval of Q1 2026 Consolidated Financial Report

Synergy Medical announced that its board of directors approved the consolidated financial report for… · 2026-05-06

【SynerG】The company's outstanding balance of capital loans has reached the announcement standard of Article 22, Paragraph 1, Subparagraph 3 of the 'Regulations Governing Loaning of Funds and Endorsements/Guarantees by Public Companies'

SynerG provided capital loans totaling NT$2,905,000 thousand to multiple subsidiaries for operationa… · 2026-05-06

【Cheng Yeh Medical】Announcement of the expected board resolution date for the company's 2026 Q1 consolidated financial report

Cheng Yeh Medical announced that its 2026 Q1 consolidated financial report is expected to be resolve… · 2026-04-28

[Excelsior Medical] Board of Directors' Resolution to Conduct a Private Placement of Common Shares

Excelsior Medical's board approved a private placement of up to 20 million common shares targeting s… · 2026-04-22